EXHIBIT 32.1

CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002

Pursuant to Section 905 of the Sarbanes-Oxley Act of 2002 (subsections (a) and
(b) of Section 1350, Chapter 63 of Title 18, United States Code), I, Jean-Luc
Berger, President and Chief Executive Officer of Kyto Biopharma, Inc., a Florida
corporation (the "Company"), do hereby certify, to the best of my knowledge,
that:

       (1)    the Company's Quarterly Report on Form 10-QSB for the three months
              ended June 30, 2004, as filed with the Securities Exchange
              Commission on the date hereof (the "Report") fully complies, in
              all material respects, with the requirements of Section 13(a) or
              15(d) of the Securities Exchange Act of 1934, as amended; and

       (2)    the information contained in the Report fairly presents, in all
              material respects, the financial condition and results of
              operations of the Company for the periods presented therein.

 Date:  August 13, 2004
                                        By:  /s/ Jean-Luc Berger
                                             -----------------------------------
                                             Jean-Luc Berger
                                             President & Chief Executive Officer